Middle East
GDN Online App available on
App Store / Play Store
Gulf Daily News Gulf Daily News
Gulf Daily News Gulf Daily News Gulf Daily News Gulf Daily News Gulf Daily News
Tuesday, January 22, 2019 ARCHIVES  |  SEARCH  |  POST ADS  |  ADVERTISE  |  SUBSCRIBE   |  LOGIN   |  CONTACT US

Healthcare group Sanofi to buy Ablynx for 3.9 billion euros

International Business
Mon, 29 Jan 2018

Paris: Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), the companies said on Monday, marking the French drug maker's second major takeover deal this month following its acquisition of Bioverativ.

The companies said Sanofi would pay 45 euros per share in cash for Ablynx, a premium of 21.2 percent over the Belgian firm's closing stock price on Friday. The deal comes after Ablynx rejected a lower offer from Denmark's Novo Nordisk .

"With Ablynx, we continue to advance the strategic transformation of our research and development, expanding our late-stage pipeline and strengthening our platform for growth in rare blood disorders," Sanofi Chief Executive Officer Olivier Brandicourt in the companies' joint statement.

You Might Like